OpiCalc Logo

OpiCalc

1332 Clinical Tools

Logo
OpiCalc
AAST Bladder Injury ScaleAAST Renal Injury ScaleAAST Urethral Injury ScaleBPH Impact IndexBosniak ClassificationCAPRA ScoreD'Amico Risk ClassificationEAU NMIBC Risk Groups (2021)EORTC Risk Tables for NMIBCFournier's Gangrene Severity IndexGUPI (Genitourinary Pain Index)Guy's Stone ScoreICIQ-UI SFIGCCCG ClassificationIIEF-5 / SHIMIIQ-7IMDC (Heng) Risk CriteriaIPSS ScoreNIH-CPSIOAB-V8PADUA Prediction ScorePI-RADS v2.1PSA DensityR.E.N.A.L. Nephrometry ScoreResidual Volume (PVR)S.T.O.N.E. NephrolithometrySFU Hydronephrosis GradingUDI-6VUR Grading
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for doctors. Always free.

Non-Custodial
bedside-Ready

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Response time:
Typically < 24 hours.

Clinical Notice:Calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for professional clinical judgment. OpiCalc is an auxiliary reference tool for qualified healthcare professionals.

OpiCalc © 2018-2026

•

All Rights Reserved

Validated • Peer-Reviewed • Instant

Recent Journal Updates

Intensive Care MedicineApr 27, 2026
Restrictive nutrition in shock: reassuring renal signals—but no proof of safety

Clinical Context

We think this has broad domain relevance to ICIQUISF.

DiabetologiaApr 24, 2026
Perspectives on human adipose tissue: from cellular mechanisms to clinical complications

Clinical Context

We think this has broad domain relevance to ICIQUISF.

DiabetologiaApr 24, 2026
Causal relationship between epigenetic markers and type 2 diabetes in West African&#xa0;populations: a Mendelian randomisation analysis

Clinical Context

We think this has broad domain relevance to ICIQUISF.

ICIQ-UI SF

Urinary Incontinence Assessment

ICIQ-UI Short Form

0 = Not at all10 = A great deal

Awaiting Responses

Answer the 3 scored questions to calculate incontinence severity.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use the ICIQ-UI SF

Initial screening and assessment of urinary incontinence (stress, urgency, mixed, overflow, or continuous) in women and men
Baseline evaluation before any incontinence treatment (pelvic floor therapy, medications, pessary, or surgery)
Monitoring treatment response at 6–12 weeks and 3–12 months post-intervention
Clinical trials as a primary or secondary outcome measure (highly responsive to change)
Screening in high-risk populations: postpartum women, postmenopausal women, elderly, post-prostatectomy men, neurogenic bladder (MS, Parkinson’s, stroke), obesity, diabetes
Differentiating incontinence types using the diagnostic question (Q4)
Quality improvement programs and benchmarking incontinence severity in clinical practice

Clinical Utility

The ICIQ-UI SF is a brief, robust, and internationally validated tool that evaluates the frequency and amount of urine leakage as well as its impact on quality of life. It is recommended by the International Continence Society (ICS) and is widely used due to its simplicity, excellent psychometric properties, and availability in over 50 languages. It correlates well with objective measures such as the pad test and is sensitive to clinically meaningful change.

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the Iiq 7, Udi 6, Oab V8, or the Ipss to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Related Urology Tools

IIEF-5 / SHIM
IMDC
Fournier's Gangrene Severity Index
AAST Renal Injury Scale
BPH Impact Index
CAPRA Score
IIQ-7
Bosniak Classification
EORTC Risk Tables for NMIBC
AAST Bladder Injury Scale
Urology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.